Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
Source:
cnbc
November 9, 2026 · 05:27
From the publisher
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
About the source
CNBC
The Consumer News and Business Channel (CNBC) is an American business news channel owned by Versant. The network broadcasts live business news and analysis programming during the morning, daytime business day, and early-evening hours, with the remaining hours filled by business-related documentaries and reality television programming, as well as occasional sports presentations from USA Sports. CNBC operates an accompanying financial news website, CNBC.com, which includes news articles, video and…
Wikidata Q1023912
Wikidata ↗
The original article opens on the publisher's website.
More from General
View topic →Commerce Dept. Chip Inquiry Was Halted After Nvidia Intervention
nytimes
Nov 9, 2026 · 08:02
Weekend trading of Nvidia scandal shines light on new financial products
cnbc
Nov 9, 2026 · 07:31
Trump questions midterm election results, revives voting-machine conspiracy
cnbc
Nov 9, 2026 · 07:28
Google’s AI chip push adds more pressure on Nvidia
coinDesk
Nov 9, 2026 · 07:20
North Korean hackers are creating memecoins to wash loot from $6.3 billion Binance hack
coinDesk
Nov 9, 2026 · 07:00